Senores Pharmaceuticals schedules analyst meet on June 9
Senores Pharmaceuticals has scheduled an analyst and institutional investor meeting on June 9, 2026, hosted by Macquarie in Mumbai. The physical group meeting will be held from 1:30 PM to 2:30 PM IST, complying with SEBI Regulation 30(6).

*this image is generated using AI for illustrative purposes only.
Senores Pharmaceuticals has scheduled an analyst and institutional investor meeting on June 9, 2026. The meeting is intended to engage with market analysts and institutional investors to discuss the company's performance and outlook.
The session will be hosted by Macquarie and will take place in Mumbai. It is scheduled as a physical group meeting, providing a platform for direct interaction between the company's management and investors.
The meeting is set to occur from 1:30 PM to 2:30 PM IST. This initiative follows the disclosure requirements under Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (SEBI) regulations.
Meeting Details
| Date & Time | Host | Nature of Meeting | Place | Mode |
|---|---|---|---|---|
| June 9, 2026 01:30 PM to 02:30 PM IST |
Macquarie | Group Meeting | Mumbai | Physical |
Historical Stock Returns for Senores Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.92% | +1.39% | +14.74% | +58.45% | +143.33% | +128.83% |
What key strategic initiatives or growth drivers is Senores Pharmaceuticals likely to highlight during the meeting?
How might the outcomes of this meeting influence investor sentiment and the company's stock performance in the near term?
What are the potential market implications of Macquarie hosting the meeting, given their role as a financial intermediary?

































